Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Inogen, Inc.

Latest From Inogen, Inc.

Inogen's Stock Collapses After Earnings Call Addressing Short-Seller Concerns

Inogen acknowledged data from its previous research firm were inaccurate on its latest investor call. A short seller recently called out Inogen for what it claimed was an overstatement of its market potential and economic projections, and has asked the company to clarify its estimates.

Business Strategies Companies

Muddy Waters Short-Sells Inogen, Citing Inflated Market Projections

The short seller that took on St. Jude Medical two years ago on cardiac-device cybersecurity now is targeting Inogen, maker of portable oxygen concentrators. Muddy Waters says the research firm that projected Inogen’s market penetration is way off and the company’s leadership is far too optimistic.

Cybersecurity Business Strategies

Device Company Reports Data Breach

Oxygen device manufacturer Inogen is recovering from a data breach. The company disclosed in a financial filing that hackers accessed private data from approximately 30,000 customers.

Cybersecurity Digital Health

Execs On The Move, March 2017

Recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.

Leadership BioPharmaceutical
See All

Company Information

  • Industry
  • Medical Devices